NYSE · Healthcare
U S PHYSICAL THERAPY INC /NV (USPH)
As-reported financials and recent SEC filings for U S PHYSICAL THERAPY INC /NV, latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.
Snapshot
Revenue
$781.0M
Net income
$39.6M
Net margin
5.1%
Diluted EPS
$1.42
ROE
8.3%
P/E (TTM)
137.6×
Market cap
$1.05B
Debt / equity
0.3×
Income statement (as reported)
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $781.0M | $671.3M | $604.8M | $553.1M | $495.0M |
| Gross profit | — | — | — | — | — |
| Operating income | $86.7M | $63.0M | $50.5M | $56.8M | $70.6M |
| Net income | $39.6M | $31.4M | $28.2M | $32.2M | $40.8M |
| Diluted EPS | $1.42 | $1.84 | $1.28 | $2.25 | $2.41 |
Source: company XBRL financial statements on SEC EDGAR.
Recent SEC filings
42026-06-22
View on EDGAR →42026-06-22
View on EDGAR →42026-06-10
View on EDGAR →4/A2026-05-28
View on EDGAR →4/A2026-05-28
View on EDGAR →4/A2026-05-28
View on EDGAR →4/A2026-05-28
View on EDGAR →4/A2026-05-28
View on EDGAR →Go deeper on USPH
Search U S PHYSICAL THERAPY INC /NV’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.
Start freeData sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.